Wharton’s jelly-derived Mesenchymal Stem Cells (hWJMSC)
Essent Biologics’ Wharton’s Jelly-derived Mesenchymal Stem Cells (hWJMSC) are isolated from human umbilical cord tissue and cryopreserved at Passages 1 and 2.
- Originates from a single donor and is proven to differentiate in vitro toward chondrogenic, osteogenic and adipogenic lineages
- Aseptically manufactured and tested for mycoplasma, bacteria, yeast, and fungi
- Rigorously characterized to ISCT guidelines
- Comprehensive donor and bioprocess data available upon request
PRICE:
Human Mesenchymal Stem Cells (hMSCs) are a class of multipotent stem cells capable of differentiation to some cell types that naturally originate from the mesoderm. They exist in a variety of tissues such as umbilical cord, bone marrow, placental and adipose.
In addition to having multi-lineage plasticity, these stem cells have a unique secretory profile with anti-inflammatory properties. For these reasons and more, these cells are attractive both for research and therapeutics within the regenerative medicine and tissue engineering fields.
Donors used for GMP products undergo serological testing for HIV-1, Hepatitis B, and Hepatitis C. A Certificate of Analysis and donor data can be provided for each cell lot purchased.
Essent’s Wharton’s Jelly-derived hMSCs are characterized for identity, purity, viability, expansion potential, and functionality in vitro (differentiation and immunomodulatory potential).
- Derived from ethically sourced human umbilical cord tissue
- ≥1M viable cells per vial post-thaw
- Multiple vials derived from single donors
- Phenotypically characterized to ensure the ISCT Minimal Criteria for Defining Multipotent Mesenchymal Stromal Cells are met
- Batch-specific protocols provided
- This product is for research use only and cannot be used in humans or as part of a clinical trial without further manufacturing.
- Certificate of Analysis
- hWJMSC Instructions for Use
- Storage: Liquid Nitrogen
- Shipped In: Dry Ice
- Shipped via: FedEx or Quick, or as coordinated by the customer
Wharton’s jelly-derived Mesenchymal Stem Cells (hWJMSC)
